Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chronic restlessness with antipsychotics.

× No keyword cloud information.

11 in total

1. Movement disorders induced by antipsychotic drugs: implications of the CATIE schizophrenia trial.

Authors: Stanley N Caroff; Irene Hurford; Janice Lybrand; E Cabrina Campbell
Journal: Neurol Clin Date: 2011-02 Impact factor: 3.806

2. Effort-Based Decision-Making Paradigms for Clinical Trials in Schizophrenia: Part 1—Psychometric Characteristics of 5 Paradigms.

Authors: L Felice Reddy; William P Horan; Deanna M Barch; Robert W Buchanan; Eduardo Dunayevich; James M Gold; Naomi Lyons; Stephen R Marder; Michael T Treadway; Jonathan K Wynn; Jared W Young; Michael F Green
Journal: Schizophr Bull Date: 2015-07-03 Impact factor: 9.306

Review 3. Severe agitation in depression precipitated by dasatinib.

Authors: Musa Basseer Sami; Farida Yousaf; Antonio Fialho
Journal: BMJ Case Rep Date: 2014-08-12

4. Effort-Based Decision-Making Paradigms for Clinical Trials in Schizophrenia: Part 2—External Validity and Correlates.

Authors: William P Horan; L Felice Reddy; Deanna M Barch; Robert W Buchanan; Eduardo Dunayevich; James M Gold; Steven R Marder; Jonathan K Wynn; Jared W Young; Michael F Green
Journal: Schizophr Bull Date: 2015-07-23 Impact factor: 9.306

5. Lack of tolerable treatment options for patients with schizophrenia.

Authors: Leslie Citrome; Anna Eramo; Clement Francois; Ruth Duffy; Susan N Legacy; Steve J Offord; Holly B Krasa; Stephen S Johnston; Alice Guiraud-Diawara; Siddhesh A Kamat; Patricia Rohman
Journal: Neuropsychiatr Dis Treat Date: 2015-12-16 Impact factor: 2.570

Review 6. Revisiting Antipsychotic-induced Akathisia: Current Issues and Prospective Challenges.

Authors: Haitham Salem; Caesa Nagpal; Teresa Pigott; Antonio Lucio Teixeira
Journal: Curr Neuropharmacol Date: 2017 Impact factor: 7.363

7. Characteristics of Patients Experiencing Extrapyramidal Symptoms or Other Movement Disorders Related to Dopamine Receptor Blocking Agent Therapy.

Authors: Shaina Musco; Laura Ruekert; Jaclyn Myers; Dennis Anderson; Michael Welling; Elizabeth Ann Cunningham
Journal: J Clin Psychopharmacol Date: 2019 Jul/Aug Impact factor: 3.153

8. Current awareness: pharmacoepidemiology and drug safety.

Authors:
Journal: Pharmacoepidemiol Drug Saf Date: 2008-06 Impact factor: 2.890

9. Extrapyramidal side effects in first-episode schizophrenia treated with flupenthixol decanoate.

Authors: Francois-Pierre Joubert; Bonginkosi Chiliza; Robin Emsley; Laila Asmal
Journal: S Afr J Psychiatr Date: 2021-01-11 Impact factor: 1.550

Review 10. Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practice.

Authors: Robert A Hauser; Jonathan M Meyer; Stewart A Factor; Cynthia L Comella; Caroline M Tanner; Rose Mary Xavier; Stanley N Caroff; Leslie Lundt
Journal: CNS Spectr Date: 2020-11-20 Impact factor: 4.604